Integrilin, Injektionslösung
7680540500111
CH-54050
B01AC16
06.03.2.
1 / 3
google
Details
- Product number
- 5405001
- CPT
- -
- Packaging group
- 10
- Unit
- ml
- Composition
- eptifibatidum 2 mg, acidum citricum monohydricum, natrii hydroxidum q.s. ad pH, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 1.38 mg.
Articles (1)
Integrilin, Injektionslösung
Injektionslösung
10
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.38 MG | Substance | HBESI |
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 54050
- Drug name
- Integrilin, Injektionslösung
- Galenic form
- LSPA
- ATC Code
- B01AC16
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 27/02/1997
- Authorization expiration date
- 30/11/2025
- IT number
- 06.03.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- INTEGRILIN sol inj 10 ml
- Description (DE)
- INTEGRILIN Inj Lös 10 ml
- Market launch
- 31/01/2013
- Market withdrawal
- 25/10/2023
- Narcotic (BTM)
- No